Pharmafile Logo
Pharmafocus logo
Advanced Search
Logos

AstraZeneca and Peregrine in immuno-oncology collaboration

August 24, 2015
Research and Development AstraZeneca, Cancer, MEDI4736, Peregrine, Peregrine Pharmaceuticals, bavituximab, durvalumab, immunoncology, immunotherapy, oncology, tumours

AstraZeneca and Peregrine Pharmaceuticals will collaborate on a clinical trial to test two of the companies’ cancer treatments. The Phase …

News
Health secretary Jeremy Hunt

Doctors ‘face jail over pharma payments’

August 24, 2015
Sales and Marketing ABPI, Jeremy Hunt, NHS, PMCPA, bribery, doctor payments, health secretary, transparency

Healthcare professionals who have inappropriate financial links with pharma companies will face prosecution and up to 10 years in jail, …

News

Takeda gets European MAA approval for ixazomib

August 21, 2015
Medical Communications, Research and Development (FDA/EMA/MHRA), FDA/EMA/MHRA, Takeda, ixazomib, multiple myeloma

Takeda has announced that the European Medicines Agency (EMA) has accepted its Marketing Authorisation Application (MAA) for ixazomib, an investigational …

News
novartis

Novartis buys rights to GSK MS drug for up to $1 billion

August 21, 2015
Medical Communications, Research and Development, Sales and Marketing GlaxoSmithKline, Novartis, multiple sclerosis, ofatumumab

Novartis has added to its burgeoning multiple sclerosis portfolio with the $300 million acquisition of all outstanding rights to GlaxoSmithKline’s …

News
lilly_corporate_hq

Lilly and Boehringer’s Jardiance diabetes drug reduces cardiovascular risks

August 21, 2015
Medical Communications, Research and Development Boehringer Ingelheim, Eli Lilly, diabetes drugs

Eli Lilly’s diabetes drug Jardiance (empagliflozin) has shown in a study to be the very first blood sugar lowering drug …

News
sun_pharma_hq

Sun Pharma gets FDA approval for acne treatment

August 21, 2015
Medical Communications, Research and Development, Sales and Marketing Sun Pharma. acne treatments, drug approvals

The FDA has approved Sun Pharma’s new acne treatment, Ximino.The Ximino (minocycline hydrochloride) extended-release capsules, which will be available in …

News

Horizon Pharma receives third rejection from Depomed

August 21, 2015
Sales and Marketing Depomed, Horizon Pharma, pharma mergers and acquisitions

Depomed has announced that its board has unanimously rejected Horizon Pharma’s third proposal to buy the California-based company. Following its …

News
259612

Monique Levy joins Google’s healthcare advisory board

August 20, 2015
Medical Communications google

Monique Levy, vice president of digital innovation at healthcare data and analytics firm Decision Resources Group, is joining Google’s healthcare …

Appointment
Pharma pill manufacturing

FDA hits Mylan’s Indian plants with warning letter

August 20, 2015
Manufacturing and Production Contamination, FDA, Mylan, Pfizer, manufacturing, production

The FDA has served Mylan with a warning letter citing contamination at three of its manufacturing facilities in India. Inspections …

News
Advanced melanoma

Novartis and Merck skin cancer drugs move through pipeline

August 20, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Merck, Novartis, Odomzo, basal cell carcinoma, keytruda, melanoma, pembrolizumab, skin cancer, sonidegib

Both Novartis and Merck have hit regulatory milestones with their skin cancer drugs in the EU and the US. Novartis’ …

News
Sprout sign

Valeant confirms $1bn deal for ‘female viagra’ creator Sprout

August 20, 2015
Manufacturing and Production, Sales and Marketing Addyi, Sprout, Sprout Pharma, Sprout Pharmaceuticals, Valeant, flibanserin

Canada’s Valeant Pharmaceuticals has confirmed it will pay $1 billion to acquire Sprout Pharmaceuticals, the company behind the female libido …

News

Lundbeck sheds 1,000 jobs in £284 million restructure

August 20, 2015
Manufacturing and Production, Sales and Marketing Lundbeck, generics, job losses, patents, redundancies, restructure, restructuring

Lundbeck is cutting a thousand jobs globally as part of a restructuring programme to significantly lower its cost and focus …

News
amgen_flag

Amgen agrees to $71m settlement over false advertising

August 19, 2015
Sales and Marketing Amgen, Aranesp, Enbrel

Amgen has reached a $71 million settlement with 48 US states and the District of Columbia, to resolve allegations that …

News
Sprout sign

FDA approves ‘female viagra’

August 19, 2015
Research and Development, Sales and Marketing Addyi, FDA, HSDD, Sprout, Sprout Pharmaceuticals, flibanserin, hypoactive sexual desire disorder

The FDA has approved Sprout Pharmaceuticals’ Addyi, a controversial libido-enhancing drug for women that has been dubbed the ‘female viagra’. …

News
BioScience Nottingham

Nottingham receives go ahead for new £30m life science facility

August 19, 2015
Manufacturing and Production, Research and Development BioCity Nottingham, R&D

Hundreds of pharma jobs are expected to be created in Nottingham after the construction of a new £30 million life …

News

Confronting the ‘danger’ of blocking progress on clinical trial transparency

August 19, 2015
Research and Development EMIG, Ethical Medicines Industry Group, Richmond Pharmacology, clinical trial registration, clinical trial transparency, health research authority, hra, sense about science, transparency

The Ethical Medicines Industry Group and Sense About Science – a co-founder of the ALLTrials campaign – have written a …

Feature

HRA must continue ‘progress towards clinical trial transparency’

August 19, 2015
Research and Development EMIG, Ethical Medicines Industry Group, Richmond Pharmacology, clinical trial registration, clinical trial transparency, health research authority, hra, sense about science, transparency

Campaigners and industry leaders have urged the Health Research Authority to ensure that its work to bring about full transparency …

News
car_t-cells

Kite Pharma says trial death was unrelated to KTE-C19

August 18, 2015
Medical Communications, Research and Development CAR-T, cinical trials, kite pharma, non-Hodgkin's lymphoma, non-Hodgkin’s lymphoma

Kite has confirmed last week’s rumours that a patient had died during its Phase I/II trial for the KTE-C19 non-Hodgkin’s …

News
ALS research

Biogen collaborates with ALSA and Columbia University on genomic-based ALS treatments

August 18, 2015
Research and Development

Biogen, the ALS Association and Columbia University Medical Center (CUMC) have announced a new collaboration aimed at better understanding the differences …

News

Birmingham opens BioHub for life science start-ups

August 18, 2015
Manufacturing and Production Birmingham, Diagnostics, hubs, life sciences, research hubs, start-ups

A £7 million biomedical laboratory has opened in Birmingham to attract life-science researchers and start-ups.  The BioHub is a new …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026